Neurological research constitutes a vast array of scientific inquiries focused on unraveling the structure, function, development, and disorders of the nervous system. This interdisciplinary field integrates knowledge from neuroscience, molecular biology, genetics, physiology, pharmacology, and psychology to elucidate the intricacies of the brain and its associated structures. Spanning from basic science investigations elucidating fundamental mechanisms of neuronal signaling, synaptic plasticity, and neural circuitry to translational and clinical research aimed at developing diagnostic tools, therapeutic interventions, and preventive strategies for neurological disorders, this research domain is dynamic and multifaceted. Recent breakthroughs in neuroimaging, genetics, stem cell biology, and neurotechnology have revolutionized our understanding of brain function and dysfunction, opening new avenues for diagnosis and treatment. Collaborations between researchers, clinicians, industry partners, and patient advocacy groups are driving innovation and accelerating the translation of scientific discoveries into clinical applications, essential for addressing the intricate challenges posed by neurological disorders and improving patient outcomes. In summary, neurological research is a rapidly evolving field that plays a pivotal role in advancing our understanding of the nervous system and developing effective strategies to prevent, diagnose, and treat neurological disorders. Through the power of scientific inquiry and innovation, neurological research holds the potential to transform healthcare and enhance the lives of millions worldwide.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States